Agreed, the whole system is not setup to handle an immediate crisis. But this has spotlighted some of the issues, one being leronlimab was developed 21 years ago now, and selected back then because of its very unique MOA and it is still not approved. Obviously, there is some issues with the current system, which more and more people are starting to see now.